Skip to main content
. 2020 Aug 29;34(12):e23542. doi: 10.1002/jcla.23542

Table 2.

The characteristics of aSAH patients between the two groups at 3 mo postoperatively

Variables Favorable prognosis Poor prognosis Total P
GCS score, n (%)
3‐8 22 (10.95) 21 (61.80) 43 (18.40) H = 54.46 <.001
9‐12 10 (4.98) 4 (11.80) 14 (6.00)
13‐15 168 (83.58) 9 (26.50) 177 (75.60)
Rebleeding or death 24 h after onset a , n (%)
None 196 (99.49) 32 (94.12) 228 (98.70) .054
Rebleeding or death 1 (0.51) 2 (5.88) 3 (1.30)
HDL b , mmol/L, M(P25, P75) 1.35 (1.15, 1.59) 1.30 (1.10, 1.77) 1.34 (1.14, 1.62) z = 1.39 .326
LDL, mmol/L, (x¯±s)/M(P25, P75) 3.14 ± 0.89 2.90 ± 0.99 3.11 (2.55,3.60) t = 1.35 .177
NLR c ,x¯±s 7.04 (5.10, 11.62) 11.20 (7.17, 17.44) 7.37 (5.54, 12.31) t′ = −3.68 .001
PLR c , M(P25, P75) 157.39 (111.90, 203.56) 180.80 (122.00, 252.88) 160.79 (112.30, 206.81) t′ = −2.23 .033
HR c , beats/min,x¯±s 81.51 ± 9.48 89.50 ± 16.79 82.67 ± 11.17 t′ = −2.70 .010
WBC count,x¯±s 13.89 ± 4.64 17.04 ± 4.74 14.34 ± 4.77 t = −3.61 <.001
PLT count,x¯±s 229.73 ± 56.97 227.48 ± 67.09 229.41 ± 58.35 t = 0.20 .838
NEUT,x¯±s 11.49 ± 4.48 14.65 ± 4.27 11.93 ± 4.58 t = 3.79 <.001
LC b , M(P25, P75) 1.50 (1.10, 2.00) 1.10 (0.90, 1.90) 1.40 (1.10, 2.00) z = 1.53 .295
AST, U/L,x¯±s 26.61 ± 12.84 32.79 ± 15.09 27.50 ± 13.33 t = −2.45 .015
Albumin, g/L,x¯±s 42.85 ± 4.35 40.50 ± 6.06 42.51 ± 4.70 t = 2.70 .008
FBG c , mmol/L,x¯±s 7.02 ± 2.53 8.69 ± 3.39 7.22 ± 2.69 t′ = −2.32 .028

Abbreviations: AST, glutamic oxaloacetic transaminase; FBG, fasting blood‐glucose; GCS, Glasgow Coma Scale; HDL, high‐density lipoprotein; HR, heart rate; LC, lymphocyte count; LDL, low‐density lipoprotein; NEUT, neutrophil count; NLR, neutrophil‐lymphocyte ratio; PLR, platelet‐lymphocyte ratio; PLT, platelet; WBC, white blood cell.

a

Using Fisher test;

b

Using Mann‐Whitney U test;

c

Using t test.